Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
The Effect Of The Novel Phosphodiesterase-4 Inhibitor MEM 1414 On The Allergen-induced Responses In mild Asthma — Brianr R. Leaker (2010) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
The Effect Of The Novel Phosphodiesterase-4 Inhibitor MEM 1414 On The Allergen-induced Responses In mild Asthma
Shared by
Peter J Barnes
Imperial College London
The Effect Of The Novel Phosphodiesterase-4 Inhibitor MEM 1414 On The Allergen-induced Responses In mild Asthma
Article
2010
en
Authors
+3 more
BL
Brianr R. Leaker
DS
Dave Singh
Peter J Barnes
Imperial College London
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2014
The effect of the novel phosphodiesterase-4 inhibitor MEM 1414 on the allergen induced responses in mild asthma
Brian Leaker
,
Dave Singh
,
Ferhana Y. Ali
,
Peter J Barnes
,
Brian O’Connor
Article
2013
The effect of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild to moderate asthma
Brian Leaker
,
Brian O’Connor
,
Peter J Barnes
,
L R McKenzie
,
David Chernoff
,
Judith Neville
,
Pat Tam
,
Grant R. Stenton
,
Curtis Harwig
,
Tom MacRury
Article
2016
A novel inhaled phosphodiesterase 4 inhibitor (CHF6001) reduces the allergen challenge response in asthmatic patients
Dave Singh
,
Brian Leaker
,
Malcolm Boyce
,
Marie Anna Nandeuil
,
Sara Collarini
,
Fabrizia Mariotti
,
Debora Santoro
,
Peter J Barnes
Article
2014
The effects of the novel <scp>SHIP</scp>1 activator <scp>AQX</scp>‐1125 on allergen‐induced responses in mild‐to‐moderate asthma
Brian Leaker
,
Peter J Barnes
,
Brian O’Connor
,
Ferhana Y. Ali
,
Patrick Tam
,
Judith Neville
,
Lloyd Mackenzie
,
Thomas MacRury
Article
1996
Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma.
David J. Evans
,
Peter J Barnes
,
Stephen M. Spaethe
,
E. L. van Alstyne
,
Melissa Mitchell
,
Brian O’Connor
Discussion(0)
No comments yet. Be the first to comment.